Hypotestosterone in Male with Obesity
DOI:
https://doi.org/10.24293/ijcpml.v27i2.1525Keywords:
Male, obesity, visceral, testosterone, hypotestosteroneAbstract
Obesity can be defined as the excess of body fat. The prevalence of obesity worldwide increases in the last decades and
causes a higher risk of cardiovascular diseases. Male subjects tend to develop visceral (abdominal) obesity, which produces
pro-inflammatory adipokines. Obesity in males is associated with low testosterone levels. Several mechanisms have been
proposed to explain the link between male obesity and hypotestosterone, including increased aromatization of
testosterone to form estradiol, suppressing the Hypothalamus-Pituitary (HPT) axis due to pro-inflammatory adipokines, and
decrease of Sex Hormone Binding Globulin (SHBG) production. Because hypotestosterone in males with obesity is a
functional but reversible condition, it is essential to screen testosterone levels in obese males for early intervention and
treatment.
Downloads
References
Wilborn, C, Beckham J, Campbell B, Harvey T,
Galbreath M, Bounty PL, et al. Obesity: Prevalence,
theories, medical consequences, management, and
research directions. Journal of the International
Society of Sport Nutrition, 2005; 2(2): 4-31.
Rachmi CN, Li M, Baur LA. Overweight and obesity in
Indonesia: Prevalence and risk factors- a literature
review. Public Health, 2017; 147: 20-29.
Fui MNT, Dupuis P, Grossmann M. Lowered
testosterone in male obesity: Mechanisms, morbidity,
and management. Asian Journal of Andrology, 2014;
: 223-231.
Guyton AC, Hall JE. Metabolism and temperature
regulation. In textbook of medical physiology.
Philadelphia, Saunders Elsevier, 2011; 843-857.
WHO. Obesity and overweight [Online]. 2017
Available: http://www.who.int/mediacentre/
factsheets/fs311/en/ (accessed 1 May, 2018).
Despres JP. Abdominal obesity: The most prevalent
cause of the metabolic syndrome and related
cardiometabolic risk. European Heart Journal
Supplements, 2006; 8(supplement B): B4-B12.
Hohl A. Testosterone from basic to clinical aspects.
Springer, Switzerland, 2017; 149-159.
MayoClinic. Testosterone, total, bioavailable, and free,
serum [Online]. 2018. Available:https://www.
mayomedicallaboratories.com/test-catalog/
Clinical+and+Interpretive/83686 (accessed 15 May,
.
Guyton AC, Hall JE. Reproductive and hormonal
functions of the male. In textbook of medical
th physiology. 12 Ed., Philadelphia, Saunders Elsevier,
; 973-986.
Durdiakova J, Ostatnikova D, Celec P. Testosterone
and its metabolites-modulators of brain functions.
Acta Neurobiol Exp, 2011; 71: 434-454.
Kelsey, TW, Li LQ, Mitchell RT, Whelan A, Anderson RA,
Wallace WHB. A validated age-related normative
model for male total testosterone shows increasing
variance but no decline after age 40 years. PLoS One,
; 9(10): e109346.
Gronowski A M. Reproductive Disorders. In: Burtis CA,
Ashwood ER, Bruns DE. (eds.) Tietz textbook of clinical
th chemistry and molecular diagnostics. 6 Ed., St. Louis,
Saunders Elsevier, 2008; 780-801.
Cooper LA, Page ST, Amory JK, Anawalt BD,
Matsumoto AM. The association of obesity with sex
hormone-binding globulin is stronger than the
association with aging – implications for the
interpretation of total testosterone measurements.
Clin Endocrinol (Oxf), 2015; 83: 828-833.
Melmed S, Polonsky KS, Larsen P, Kronenberg H.
Williams textbook of endocrinology. Philadelphia,
Elsevier, 2016; p645-698.
Krakowsky Y, Conners W, Morgentaler A. Serum
concentrations of sex hormone-binding globulin vary
widely in younger and older men: Clinical data from a men's health practice. Eur Urol Focus, 2017; 1-7.
Stanczyk FZ, Bretsky P. Biosynthesis, transport, and
metabolism of steroid hormones. In: Henderson BE,
Ponder B, Ross RK. (eds.) Hormones, genes, and
cancer. New York, Oxford University Press, 2003;
-37.
Hammond GL. Sex hormone-binding globulin and the
metabolic syndrome. In: Winters SJ, Huhtaniemi IT.
nd (eds.). Male hypogonadism. 2 Ed., New York,
Humana Press, 2017; 305-324.
Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H,
Eriksson KL, et al. Relationship between testosterone
levels, insulin sensitivity, and mitochondrial function
in men. Diabetes Care, 2005; 28: 1636-1642.
Bhasin S. Effect of testosterone administration on fat
distribution, insulin sensitivity, and atherosclerosis
progression. Clinical Infectious Disease, 2003; 37(2):
S142-149.
Bianchi VE. Metabolic syndrome, obesity paradox, and
testosterone level. Endocrinol Metab Synd, 2015; 4(2):
-16.
Pasquali R, Vicennati V, Gambineri A, Pagotto U.
Sex-dependent role of glucocorticoids and
androgens in the pathophysiology of human obesity.
International Journal of Obesity, 2008; 32: 1764-1779.
Mogri M, Dhindsa S, Quattrin T, Ghanim H, Dandona P.
Testosterone concentration in young pubertal and
post-pubertal obese males. Clin Endocrinol (Oxf),
; 78(4): 593-599.
Wang C, Jackson G, Jones TH, Matsumoto AM, Nehra
A, Perelman MA, et al. Low testosterone associated
with obesity and the metabolic syndrome contributes
to sexual dysfunction and cardiovascular disease risk
in men with type 2 diabetes. Diabetes Care, 2011; 34:
-1673.
Tremellen K, Pearce K. Nutrition, fertility, and human
reproductive function. Florida, CRC Press, 2015;
-261.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
